绥美凯在美国的价格贵吗

As a new AIDS treatment drug, Suimeikai (dolute abalamib tablets) has received priority review approval from the CFDA. Suimeike is the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of high efficacy, good tolerance, high resistance barrier, and few drug interactions. It can be taken once a day, one tablet each time, which can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life. Today we will take a closer look at the price of Suimeikai in the United States?

Regarding the price of Suimeikai (Doteta abalamib tablets), the original drug is relatively expensive in China. Suimeikan available in China is relatively expensive and most patients cannot afford it. The domestic price of Suimeikan is 2880$/month. Suimeikai, produced by the Indian company Emcure, comes in a box of 30 tablets and sells for about RMB 1,000. Due to the floating exchange rate, the price cannot be determined. Please consult Medical Travel for specific prices.

On January 22, 2018, GlaxoSmithKline (GSK) announced that its single-tablet compound preparation Trimeq (dolute abalamib tablets) with the new generation integrase inhibitor dolutegravir (DTG) as the core for the treatment of HIV was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.

Trimicay (dolutegravir) is a once-daily three-in-one drug developed by ViiV Healthcare, a joint venture between GlaxoSmithKline and Pfizer. The drug is based on the treatment plan of the integrase inhibitor Tivicay (Dolutegravir) and also contains two nucleoside reverse transcriptase inhibitors, Abacavir and Lamivudine. It was approved by the FDA on August 27, 2014.

The usage and dosage of Suimeikai (Dotiabalamid Tablets) is to be taken under the guidance of a physician with experience in HIV infection. Dosage: Adults and Adolescents (Weight of at least 40kg) For adults and adolescents, the recommended dose of Sumeika is one tablet, once daily. Adults or adolescents whose body weight is less than 40 kg should not be given Trimax as Trimax is a fixed-dose tablet and the dose cannot be reduced (see inner package insert for details). We need to be cautious about the usage and dosage of Suimeikai. In addition to strictly following the doctor's instructions, we also need to use it strictly in accordance with the instructions.

The above is the price content of Suimeikai (Doteta Abalamid Tablets), I hope it can help you!